TBOPP

Uses

1-(2-Oxo-2-(3''-(trifluoromethyl)-[1,1''-biphenyl]-4-yl)ethyl)-5-(pyrrolidin-1-ylsulfonyl)pyridin-2(1H)-one is a selective inhibitor of DOCK1 as a therapeutic approach to target cancer cell survival and invasion.